Infection and Immunity, March 2001, p. 1477-1482, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1477-1482.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Pathology, University of Utah
School of Medicine, Salt Lake City, Utah1;
Department of Microbiology and Immunology, Uniformed Services
University of the Health Sciences, Bethesda,
Maryland2; Department of Microbiology,
University of Alabama
Birmingham, Birmingham,
Alabama3; and Department of Animal
Health and Biomedical Sciences, University of Wisconsin at Madison,
Madison, Wisconsin4
Received 14 November 2000/Accepted 7 December 2000
Lipopolysaccharide (LPS) derived from the periodontal pathogen Porphyromonas gingivalis has been reported to differ structurally and functionally from enterobacterial LPS. These studies demonstrate that in contrast to protein-free enterobacterial LPS, a similarly purified preparation of P. gingivalis LPS exhibited potent Toll-like receptor 2 (TLR2), rather than TLR4, agonist activity to elicit gene expression and cytokine secretion in murine macrophages and transfectants. More importantly, TLR2 stimulation by this P. gingivalis LPS preparation resulted in differential expression of a panel of genes that are normally induced in murine macrophages by Escherichia coli LPS. These data suggest that (i) P. gingivalis LPS does not signal through TLR4 and (ii) signaling through TLR2 and through TLR4 differs quantitatively and qualitatively. Our data support the hypothesis that the shared signaling pathways elicited by TLR2 and by TLR4 agonists must diverge in order to account for the distinct patterns of inflammatory gene expression.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|